ArticleFrontiers in pharmacology2023

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma.

Xiwen Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.